Advertisement
Singapore markets closed

  • Straits Times Index

    3,290.70
    +24.75 (+0.76%)
     

  • Nikkei

    38,229.11
    +155.13 (+0.41%)
     

  • Hang Seng

    18,963.68
    +425.87 (+2.30%)
     

  • FTSE 100

    8,433.76
    +52.41 (+0.63%)
     

  • Bitcoin USD

    60,753.30
    -1,979.15 (-3.15%)
     

  • CMC Crypto 200

    1,259.94
    -98.07 (-7.22%)
     

  • S&P 500

    5,222.68
    +8.60 (+0.16%)
     

  • Dow

    39,512.84
    +125.08 (+0.32%)
     

  • Nasdaq

    16,340.87
    -5.40 (-0.03%)
     

  • Gold

    2,366.90
    +26.60 (+1.14%)
     

  • Crude Oil

    78.20
    -1.06 (-1.34%)
     

  • 10-Yr Bond

    4.5040
    +0.0550 (+1.24%)
     

  • FTSE Bursa Malaysia

    1,600.67
    -0.55 (-0.03%)
     

  • Jakarta Composite Index

    7,088.79
    -34.81 (-0.49%)
     

  • PSE Index

    6,511.93
    -30.53 (-0.47%)
     

Nasdaq Halts CNS Pharmaceuticals Inc.

GlobeNewswire

NEW YORK, May 18, 2020 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market® (NDAQ) announced that the trading halt status in CNS Pharmaceuticals Inc. (CNSP) was changed to "additional information requested" from the company. Trading in the company’s stock had been halted on May 4, 2020 at 9:25:06 Eastern Time at a last sale price of $2.76.

Trading will remain halted until CNS Pharmaceuticals Inc. has fully satisfied Nasdaq’s request for additional information.

For news and additional information about the company, please contact the company directly or check under the company’s symbol using InfoQuotesSM on the Nasdaq® Web site.

For more information about The Nasdaq Stock Market, visit the Nasdaq Web site at http://www.nasdaq.com.

NDAQO

Nasdaq Media Contact:
Bianca Fata
Bianca.Fata@nasdaq.com